Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Ovarian Neoplasms

  Free Subscription


Articles published in Am J Obstet Gynecol

Retrieve available abstracts of 40 articles:
HTML format



Single Articles


    November 2021
  1. SMITH MJ, Gerber D, Olsen A, Khouri OR, et al
    Uptake and timing of risk-reducing salpingo-oophorectomy among patients with BRCA1 and BRCA2 mutations.
    Am J Obstet Gynecol. 2021;225:508.
    PubMed     Abstract available


    October 2021
  2. MANDELBAUM RS, Matsuzaki S, Sangara RN, Klar M, et al
    Paradigm shift from tubal ligation to opportunistic salpingectomy at cesarean delivery in the United States.
    Am J Obstet Gynecol. 2021;225:399.
    PubMed     Abstract available


    September 2021
  3. CUSIMANO MC, Ferguson SE, Moineddin R, Chiu M, et al
    Ovarian Cancer Incidence and Death in Average-Risk Women Undergoing Bilateral Salpingo-Oophorectomy at Benign Hysterectomy.
    Am J Obstet Gynecol. 2021 Sep 23. pii: S0002-9378(21)01048.
    PubMed     Abstract available


  4. VAN LIESHOUT LAM, Gelderblom ME, DE Hullu JA, The R, et al
    Primary prevention of ovarian cancer: a patient decision aid for opportunistic salpingectomy.
    Am J Obstet Gynecol. 2021 Sep 15. pii: S0002-9378(21)01007.
    PubMed     Abstract available


    June 2021
  5. MARCHAND G, Mills K, Ware K
    Reply to a question regarding ovarian cancer prevention with partial salpingectomy versus complete.
    Am J Obstet Gynecol. 2021 Jun 30. pii: S0002-9378(21)00769.
    PubMed    


    May 2021
  6. MARCHOCKI Z, Cusimano MC, Clarfield L, Rachel Kim S, et al
    Sentinel lymph node biopsy in high-grade endometrial cancer: a systematic review and meta-analysis of performance characteristics.
    Am J Obstet Gynecol. 2021 May 28. pii: S0002-9378(21)00602.
    PubMed     Abstract available


  7. VAN WEELDEN WJ, Lalisang RI, Bulten J, Lindemann K, et al
    IMPACT OF HORMONAL BIOMARKERS ON RESPONSE TO HORMONAL THERAPY IN ADVANCED AND RECURRENT ENDOMETRIAL CANCER.
    Am J Obstet Gynecol. 2021 May 18. pii: S0002-9378(21)00554.
    PubMed     Abstract available


  8. SUH-BURGMANN E, Brasic N, Jha P, Hung YY, et al
    Ultrasound characteristics of early stage high-grade serous ovarian cancer.
    Am J Obstet Gynecol. 2021 May 13. pii: S0002-9378(21)00551.
    PubMed     Abstract available


    March 2021
  9. NAUMANN RW, Hughes BN, Brown J, Drury LK, et al
    The Impact of Opportunistic Salpingectomy on Ovarian Cancer Mortality and Healthcare Costs: A Call For Universal Insurance Coverage.
    Am J Obstet Gynecol. 2021 Mar 30. pii: S0002-9378(21)00212.
    PubMed     Abstract available


    February 2021
  10. HARRISON RF, Fu S, Sun CC, Zhao H, et al
    Patient cost-sharing during poly(ADP-ribose) polymerase inhibitor treatment in ovarian cancer.
    Am J Obstet Gynecol. 2021 Feb 4. pii: S0002-9378(21)00086.
    PubMed     Abstract available


    January 2021
  11. SCHRIJVER LH, Antoniou AC, Olsson H, Mooij TM, et al
    Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study.
    Am J Obstet Gynecol. 2021 Jan 22. pii: S0002-9378(21)00038.
    PubMed     Abstract available


  12. MATSUO K, Mandelbaum RS, Matsuzaki S, Klar M, et al
    Ovarian conservation for young women with early-stage low-grade endometrial cancer: A proposal for a two-step approach.
    Am J Obstet Gynecol. 2021 Jan 4. pii: S0002-9378(20)32630.
    PubMed     Abstract available


    December 2020
  13. MASCIULLO V, Trivellizzi N, Zannoni G, Catena U, et al
    Prognostic impact of hysteroscopic resection of endometrial atypical hyperplasia/endometrioid intraepithelial neoplasia and early-stage cancer in combination with megestrol acetate.
    Am J Obstet Gynecol. 2020 Dec 29. pii: S0002-9378(20)32627.
    PubMed     Abstract available


    August 2020
  14. HERMENS M, van Altena AM, van der Aa M, Bulten J, et al
    Ovarian cancer prognosis in women with endometriosis. A retrospective nationwide cohort study of 32,419 women.
    Am J Obstet Gynecol. 2020 Aug 22. pii: S0002-9378(20)30883.
    PubMed     Abstract available


  15. SAMIMI G, Sathyamoorthy N, Tingen CM, Mazloomdoost D, et al
    Report of NCI and NICHD-Sponsored Workshop: Gynecology and Women's Health-Benign Conditions and Cancer.
    Am J Obstet Gynecol. 2020 Aug 21. pii: S0002-9378(20)30877.
    PubMed     Abstract available


  16. WESTIN SN, Fellman B, Sun CC, Broaddus RR, et al
    Prospective Phase II Trial of Levonorgestrel Intrauterine Device: Non-Surgical Approach for Complex Atypical Hyperplasia and Early Endometrial Cancer.
    Am J Obstet Gynecol. 2020 Aug 14. pii: S0002-9378(20)30861.
    PubMed     Abstract available


  17. ALBRIGHT BB, Nasioudis D, Craig S, Moss HA, et al
    Impact of Medicaid expansion on women with gynecologic cancer: A difference-in-difference analysis.
    Am J Obstet Gynecol. 2020 Aug 7. pii: S0002-9378(20)30835.
    PubMed     Abstract available


    July 2020
  18. PADILLA-ISERTE P, Lago V, Tauste C, DIaz-Feijoo B, et al
    Impact of uterine manipulator on oncological outcome in endometrial cancer surgery.
    Am J Obstet Gynecol. 2020 Jul 18. pii: S0002-9378(20)30744.
    PubMed     Abstract available


  19. FERRARI F, Forte S, Sbalzer N, Zizioli V, et al
    Validation of an enhanced recovery after surgery protocol in gynecological surgery: an Italian randomized study.
    Am J Obstet Gynecol. 2020 Jul 8. pii: S0002-9378(20)30720.
    PubMed     Abstract available


    June 2020
  20. FREY MK, Ellis AE, Zeligs K, Chapman-Davis E, et al
    Impact of the COVID-19 Pandemic on Quality of Life for Women with Ovarian Cancer.
    Am J Obstet Gynecol. 2020 Jun 26. pii: S0002-9378(20)30674.
    PubMed     Abstract available


    May 2020
  21. VETTER MH, Smrz SA, Copeland LJ, Cohn DE, et al
    Chemotherapy directly followed by PARP inhibition as an alternative to surgery in patients with BRCA- mutated ovarian cancer - a potential management strategy in the era of COVID-19.
    Am J Obstet Gynecol. 2020 May 23. pii: S0002-9378(20)30569.
    PubMed    


  22. CHAMBERS LM, Morton M, Lampert E, Yao M, et al
    Use of Prophylactic Closed Incision Negative Pressure Therapy Is Associated with Reduced Surgical Site Infections in Gynecologic Oncology Patients Undergoing Laparotomy.
    Am J Obstet Gynecol. 2020 May 14. pii: S0002-9378(20)30536.
    PubMed     Abstract available


  23. GUO XM, Hall EF, Mazzullo L, Djordjevic M, et al
    A low-cost approach to salpingectomy at cesarean delivery.
    Am J Obstet Gynecol. 2020;222:503.
    PubMed     Abstract available


    April 2020
  24. MANDELBAUM RS, Adams CL, Yoshihara K, Nusbaum DJ, et al
    The rapid adoption of opportunistic salpingectomy at the time of hysterectomy for benign gynecological disease in the United States.
    Am J Obstet Gynecol. 2020 Apr 30. pii: S0002-9378(20)30514.
    PubMed     Abstract available


    March 2020
  25. MILLER H, Matsuo K
    A cesarean delivery sequela: Scar rupture and tumor spill during laparoscopic hysterectomy for endometrial cancer.
    Am J Obstet Gynecol. 2020 Mar 18. pii: S0002-9378(20)30337.
    PubMed    


  26. KASPERS M, Llamocca E, Quick A, Dholakia J, et al
    Black and Hispanic women are less likely than White women to receive guideline-concordant endometrial cancer treatment.
    Am J Obstet Gynecol. 2020 Mar 3. pii: S0002-9378(20)30232.
    PubMed     Abstract available


    February 2020
  27. HANLEY GE, Kwon JS, McAlpine JN, Huntsman DG, et al
    Examining indicators of early menopause following opportunistic salpingectomy: A cohort study from British Columbia, Canada.
    Am J Obstet Gynecol. 2020 Feb 14. pii: S0002-9378(20)30143.
    PubMed     Abstract available


    January 2020
  28. HERMENS M, van Altena AM, Nieboer TE, Schoot BC, et al
    Incidence of endometrioid and clear-cell ovarian cancer in histological proven endometriosis. The ENOCA population-based cohort study.
    Am J Obstet Gynecol. 2020 Jan 22. pii: S0002-9378(20)30062.
    PubMed     Abstract available


    November 2019
  29. GREGORI-GARCIA E, Rodriguez-Garcia V, Burgues O, Martinez J, et al
    Differential expression of Receptor Activator of Nuclear Factor Kappa B in healthy endometrium, ovarian endometrioma and endometrioid ovarian cancer.
    Am J Obstet Gynecol. 2019 Nov 22. pii: S0002-9378(19)32638.
    PubMed    


  30. FACER B, Wang F, Grijalva CG, Alvarez RD, et al
    Survival Outcomes for Robotic-Assisted Laparoscopy Versus Traditional Laparoscopy in Clinical Stage I Epithelial Ovarian Cancer.
    Am J Obstet Gynecol. 2019 Nov 9. pii: S0002-9378(19)32614.
    PubMed     Abstract available


    September 2019
  31. LAGO V, Domingo S
    New horizons of sentinel lymph node technique in early ovarian cancer.
    Am J Obstet Gynecol. 2019 Sep 19. pii: S0002-9378(19)31125.
    PubMed    


  32. UCCELLA S, Fagotti A, Scambia G
    SENTINEL NODE IN OVARIAN CANCER: A CHALLENGE TO WIN.
    Am J Obstet Gynecol. 2019 Sep 18. pii: S0002-9378(19)31122.
    PubMed    


    August 2019
  33. VETTER MH, Smith B, Benedict J, Hade EM, et al
    Preoperative predictors of endometrial cancer at time of hysterectomy for endometrial intraepithelial neoplasia or complex atypical hyperplasia.
    Am J Obstet Gynecol. 2019 Aug 8. pii: S0002-9378(19)31000.
    PubMed     Abstract available


    May 2019
  34. DAI Y, Zhang J, Ren H, Zhou X, et al
    Surgical outcomes in patients with anti-N-methyl D-aspartate receptor encephalitis with ovarian teratoma.
    Am J Obstet Gynecol. 2019 May 22. pii: S0002-9378(19)30684.
    PubMed     Abstract available


  35. DOLL KM, Winn A
    Assessing Endometrial Cancer Risk Among US Women: Long-Term Trends using Hysterectomy-Adjusted Analysis.
    Am J Obstet Gynecol. 2019 May 21. pii: S0002-9378(19)30682.
    PubMed     Abstract available


  36. HOLLIS RL, Carmichael J, Meynert AM, Churchman M, et al
    Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse.
    Am J Obstet Gynecol. 2019 May 2. pii: S0002-9378(19)30620.
    PubMed     Abstract available


    March 2019
  37. GIBBS J, Mei S, Economos K, Lee YC, et al
    Clinicopathologic features, incidence and survival trends of gynecologic neuroendocrine tumors; a SEER data base analysis.
    Am J Obstet Gynecol. 2019 Mar 5. pii: S0002-9378(19)30431.
    PubMed     Abstract available


    January 2019
  38. VENKATESH KK, Clark LH, Stamilio DM
    Cost-effectiveness of opportunistic salpingectomy vs tubal ligation at the time of cesarean delivery.
    Am J Obstet Gynecol. 2019;220:106.
    PubMed     Abstract available


    December 2018
  39. OKAZAKI A, Nishi K, Kasahara K
    Pseudo-Meigs Syndrome Caused by Cancer of the Uterine Corpus.
    Am J Obstet Gynecol. 2018 Dec 7. pii: S0002-9378(18)32217.
    PubMed    


    October 2018
  40. COLLINS E, Strandell A, Granasen G, Idahl A, et al
    Menopausal symptoms and surgical complications after opportunistic bilateral salpingectomy, a register-based cohort study.
    Am J Obstet Gynecol. 2018 Oct 12. pii: S0002-9378(18)30898.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ovarian Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: